Prognostic Significance of Granuloma and Amyloid Deposition in Nasopharyngeal Carcinoma.
Amyloid
Granuloma
Head and neck
Nasopharyngeal carcinoma
Radiotherapy
Journal
Head and neck pathology
ISSN: 1936-0568
Titre abrégé: Head Neck Pathol
Pays: United States
ID NLM: 101304010
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
04
05
2020
accepted:
12
06
2020
pubmed:
21
6
2020
medline:
12
11
2021
entrez:
21
6
2020
Statut:
ppublish
Résumé
The significance of granuloma and amyloid deposition in primary nasopharyngeal carcinoma (NPC) has yet to be investigated. This study aimed to evaluate their clinicopathologic associations. The histopathologic findings of 747 consecutive patients with primary NPC were retrospectively reviewed between January 2001 and December 2015. The presence of granulomas and amyloid deposits was observed in 68 (9.1%) and 62 (8.3%) patients, respectively. Granulomas were significantly associated with lower T classification, N classification, and overall TNM stage (p = 0.014, p = 0.006, and p = 0.001, respectively). Their presence was an independent predictor of overall survival (p = 0.033), disease-free survival (p = 0.034), and recurrence-free survival (p = 0.040). Conversely, amyloid deposition was not a predictor in any survival analyses. The present study demonstrated the prevalence of granuloma and amyloid deposition in the largest single institution cohort of primary NPC patients so far. Our results provide evidence that granulomas are significantly associated with better prognosis and treatment outcome. Further studies are needed to elucidate the mechanism of action of granuloma formation on the anti-tumor immunity of NPC.
Identifiants
pubmed: 32562216
doi: 10.1007/s12105-020-01194-4
pii: 10.1007/s12105-020-01194-4
pmc: PMC8010042
doi:
Substances chimiques
Amyloid
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
153-162Subventions
Organisme : Ministry of Science and Technology, Taiwan
ID : MOST105-2628-B-182A-008-MY3
Organisme : Chang Gung Memorial Hospital
ID : CMRPG2G0231
Références
JAMA. 1975 Aug 25;233(8):886-9
pubmed: 168415
J Gastrointest Oncol. 2016 Aug;7(4):E72-6
pubmed: 27512605
J Virol. 2001 Sep;75(18):8649-59
pubmed: 11507210
J Clin Oncol. 2003 Feb 15;21(4):631-7
pubmed: 12586799
Am J Surg Pathol. 2004 Mar;28(3):379-83
pubmed: 15104301
J Clin Oncol. 1998 Apr;16(4):1310-7
pubmed: 9552031
Rev Med Interne. 2008 Jan;29(1):39-45
pubmed: 18054124
Histopathology. 1991 Feb;18(2):133-41
pubmed: 1901294
Pathol Res Pract. 1986 Jun;181(3):349-56
pubmed: 3748883
Cell Rep. 2017 Apr 4;19(1):203-217
pubmed: 28380359
J Exp Med. 2000 May 15;191(10):1649-60
pubmed: 10811859
Curr Opin Oncol. 2001 Sep;13(5):349-53
pubmed: 11555711
J Formos Med Assoc. 1991 Apr;90(4):353-6
pubmed: 1717637
Int J Radiat Oncol Biol Phys. 1992;23(2):261-70
pubmed: 1587745
J Clin Invest. 2001 Jan;107(1):121-30
pubmed: 11134187
Head Neck. 2003 Jun;25(6):438-50
pubmed: 12784235
Oncol Rep. 1998 Jan-Feb;5(1):177-80
pubmed: 9458317
Br J Cancer. 1972 Apr;26(2):120-3
pubmed: 5038325
Mol Cancer Ther. 2007 Aug;6(8):2271-9
pubmed: 17671084
Semin Cancer Biol. 2012 Apr;22(2):154-61
pubmed: 22206863
J Clin Pathol. 2007 Dec;60(12):1397-402
pubmed: 18042696
Pathol Int. 2003 May;53(5):265-9
pubmed: 12713559
Cancer. 1978 Feb;41(2):562-7
pubmed: 630538
Histopathology. 1984 Jan;8(1):27-34
pubmed: 6706312